Clinical Trials

Search for trials
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 1
  • Intervention Type: Drug
  • Participants: 30
  • Start Date: September 2022
Pharmacokinetics and Pharmacodynamics of Biologic Drugs in Obese Patients With Arthritis
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 3
  • Intervention Type: Drug
  • Participants: 60
  • Start Date: July 27, 2021
A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Apremilast in Children From 5 to Less Than 18 Years of Age With Active Juvenile Psoriatic Arthritis (PEAPOD)
Search for trials
Clinical Trial
  • Status: Not yet recruiting
  • Intervention Type: Biological
  • Participants: 500
  • Start Date: June 2021
Conception of a Diagnosis, Prognosis and Therapeutic Decision Tool for Patients With Autoimmunity and Inflammation
Clinical Trial
  • Status: Enrolling by invitation
  • Phase: N/A
  • Intervention Type: Behavioral
  • Participants: 52
  • Start Date: May 20, 2021
Implementation and Effectiveness Evaluation of the iPeer2Peer Support Mentorship Program Within Pediatric Thoracic Transplantation
Clinical Trial
  • Status: Not yet recruiting
  • Intervention Type: Other
  • Participants: 300
  • Start Date: May 2021
Survey on the Expectations of Adolescents With Juvenile Idiopathic Arthritis (JIA) Regarding Knowledge and Communication With Health Care Professionals in the Field of Sexual Health, and Their Parents' Views on the Subject.
Clinical Trial
  • Status: Recruiting
  • Participants: 99
  • Start Date: May 1, 2021
An Investigation Into the Relationship Between Dietary Intake and Health-related Quality of Life in Children and Young People With Juvenile Idiopathic Arthritis
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 3
  • Intervention Type: Drug
  • Participants: 100
  • Start Date: April 13, 2021
Multicenter, Open-label, Efficacy, Safety, Tolerability, and Pharmacokinetic Study of Subcutaneous Ixekizumab With Adalimumab Reference Arm, in Children With Juvenile Idiopathic Arthritis Subtypes of Enthesitis-related Arthritis (Including Juvenile-Onset Ankylosing Spondylitis) and Juvenile Psoriatic Arthritis
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 1
  • Intervention Type: Drug
  • Participants: 12
  • Start Date: March 25, 2021
A Phase 1b, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of AEVI-007 in Subjects With Adult Onset Still's Disease
Clinical Trial
  • Status: Active, not recruiting
  • Phase: Phase 4
  • Intervention Type: Biological
  • Participants: 2067
  • Start Date: February 9, 2021
Immunogenicity and Safety of the CoronaVac Vacccine in Patients With Autoimmune Rheumatic Diseases and People Living With HIV/AIDS
Clinical Trial
  • Status: Recruiting
  • Phase: Early Phase 1
  • Intervention Type: Drug
  • Participants: 20
  • Start Date: February 1, 2021
An Exploratory Study on the Efficacy and Safety of Abatacept in the Treatment of Refractory Dermatomyositis
Clinical Trial
  • Status: Recruiting
  • Participants: 357
  • Start Date: January 1, 2021
THE INVESTIGATION OF THE SCOLIOSIS OF CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITIS AND AWARENESS OF THE PARENTS RELATED TO SCOLIOSIS
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 4
  • Intervention Type: Drug
  • Participants: 202
  • Start Date: December 1, 2020
Strategies Towards Personalised Treatment in Juvenile Idiopathic Arthritis (JIA): The MyJIA Trial.
Showing 1-12 of 56